Merit Medical Systems (MMSI) Stock: Buy, Sell, or Hold?
MMSI - Merit Medical Systems Inc
$89.20
-0.37 (-0.41%)
▼
5d:
+2.28%
30d:
+4.24%
90d:
+18.66%
HOLD
MODERATE Confidence
Analysis Updated: Oct 16, 2026 12:00 AM ET
Earnings: Oct 29, 2026
11d
Get Alerted When MMSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MMSI is fairly valued with market pricing in 2.6% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: MMSI is fairly valued with market pricing in 2.6% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$108.37
Based on 5.6% avg growth
INTRINSIC VALUE TODAY
$67.29
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MMSI is currently trading at $89.20, which is considered extended relative to its 30-day fair value range of $85.60 to $88.09. The stock's valuation (Forward PE: 19.3) is in line with its historical norms (17.9). At these levels, the market is pricing in 2.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MMSI is in a strong uptrend. The price is approaching resistance at $90.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $101.64 (+13.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MMSI is in a strong uptrend. The price is approaching resistance at $90.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $101.64 (+13.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$85.60 -
$88.09
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
49.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($101.64)
- NEUTRAL: Market pricing in 2.6% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (50/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$85.60 -
$88.09
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$83.94
Resistance Level
$90.99
Current Trend
Strong Uptrend
Technical data as of
Oct 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.34
Wall Street Target
$101.64
(+13.9%)
Revenue Growth (YoY)
9.5%
Earnings Growth (YoY)
20.4%
Profit Margin
9.2%
Valuation Premium vs History
+2.6% premium
PE vs Historical
19.3 vs 17.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.6%
(market-implied from PE analysis)
1-Year Target
$91.52
(+3%)
2-Year Target
$93.90
(+5%)
3-Year Target
$96.34
(+8%)
3-Yr Target (if PE normalizes)
(PE: 19→18)
PE COMPRESSION
$89.15
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 7.2%)
$112.79
(+26%)
Base:
(SPY PE: 19.3, Growth: 7.2%)
$109.85
(+23%)
Bear:
(PE: 16.4, Growth: 7.2%)
$93.38
(+5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 36.86 | Current EPS (TTM): $2.43
Bull Case
$186.98
(+110%)
Analyst growth 89.8%, PE expands to 40.6
Base Case
$169.98
(+91%)
Market implied 89.8%, PE stable at 36.9
Bear Case
$60.91
(-32%)
Severe decline -20.0%, PE contracts to 31.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 17, 2026 4:35 AM ET
Data refreshes hourly during market hours. Next update: 5:35 AM
Data refreshes hourly during market hours. Next update: 5:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MMSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 57 HOLD |
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
33 analysts |
$478 | 32 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$197 | 46 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$412 | 39 SELL |
|
NVST
Envista Holdings Corp |
BUY
15 analysts |
$30 | 76 BUY |